Advanced Flower Capital Inc Dossier - Source-backed chat

Advanced Flower Capital Inc

AFCGNASDAQ

SectorFinancials

IndustryAsset Management & Custody Banks

Beta (adjusted)0.95

Intrinsic Value

Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet.

Market Price $3.60Price as of 30 Sep 2026

Data confidenceNot applicable

Market Cap $80.9M

Enterprise Value $170.6M

Shares Outstanding 23.5M diluted

Next Earnings Date11 Nov 2026

Last ex-dividend30 Jun 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Advanced Flower Capital Inc. (AFCG) has successfully completed its strategic transition from a mortgage REIT to a Business Development Company (BDC) effective January 1, 2026. This structural shift expands its investment mandate beyond real estate-backed cannabis loans into a broader universe of lower middle-market companies. While Q1 2026 results demonstrated strong profitability with Net Investment Income of $0.21 per share comfortably covering the $0.05 dividend, and NAV rising to $7.90, the company continues to face significant legacy credit risks from its cannabis portfolio. Trading at a steep discount to book value, the stock offers a high yield and potential upside from its new $5 million share buyback program, but ongoing non-accruals and regulatory uncertainties warrant a cautious Hold stance.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets1 analysts · as of 18 Aug 2026

Low · most bearish analyst$8.00

Mean target$8.00

High · most bullish analyst$8.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

Deteriorating credit quality in the legacy cannabis portfolio leads to further loan defaults and write-downs, eroding NAV. Federal policy reforms face prolonged delays, keeping borrower capital costs high and restricting liquidity. New lower middle-market originations fail to offset the lost interest income from non-accruals, putting pressure on the sustainability of the $0.05 quarterly dividend and driving the stock price lower.

Base CaseCentral scenario

The company successfully manages the wind-down and restructuring of its legacy underperforming cannabis loans while steadily deploying capital into higher-quality, diversified lower middle-market senior secured loans. Distributable earnings stabilize, allowing the company to maintain its reset quarterly dividend of $0.05 per share. The stock continues to trade at a moderate discount to its NAV of $7.90, supported by the active $5 million share repurchase program.

Bull CaseUpside scenario

Advanced Flower Capital Inc. is positioned favorably to leverage its deep network and specialized expertise in cannabis and credit to enhance lending operations in a niche market. Trading at a significant discount to book value (approximately 0.7x) with a high dividend yield, the company offers strong income generation potential. Furthermore, management's proactive approach to restructuring agreements and expanding its investment mandate to include direct lending in non-cannabis middle-market companies helps mitigate portfolio risks and stabilize operations.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Strategic BDC conversion expands the investment universe and enhances operational flexibility beyond real estate-backed loans.
Strong Q1 2026 financial performance with Net Investment Income ($0.21/share) comfortably covering the quarterly dividend ($0.05/share).
Implementation of a proactive $5.0 million share repurchase program to buy back stock at or below $3.50 per share, enhancing shareholder value.
Significant valuation discount to Net Asset Value (NAV of $7.90 as of March 31, 2026).

Key Investment Risks

High concentration of legacy cannabis-related loans, which are highly sensitive to federal regulatory delays.
Deteriorating credit quality and non-accrual status of legacy loans, which historically pressured interest income.
Dividend sustainability remains dependent on successful capital redeployment and credit risk mitigation.

Thesis Invalidation Triggers

A significant drop in NAV per share below $7.00 due to unexpected credit write-downs.
Failure to cover the quarterly dividend of $0.05 with Net Investment Income.
Severe legislative setbacks regarding federal cannabis rescheduling or banking reforms.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.